HIMSS Analytics Database made available for research

Laura Pedulli | | Health Exec | Precision Medicine

The Dorenfest Institute for Health Information, managed by the HIMSS Foundation, has made available its 2012 year-end HIMSS Analytics Database.

Universities, government agencies and international governments will utilize the HIMSS Analytics data release, which includes historical data, reports and white papers about IT use, to support their research efforts to improve patient care.

The database covers IT use on nearly 5,400 U.S. hospitals and more than 26,000 ambulatory facilities that are associated with these hospitals. This release expands Dorenfest Institute's current library of databases, including the Dorenfest 3000+ Databases, the Dorenfest Integrated Healthcare Delivery System Databases and previous editions of the HIMSS Analytics Database. Data are currently available from 1986 through 2012.

In addition to the 2012 year end database, HIMSS Analytics released two research reports to the Dorenfest Institute, which include a report analyzing the healthcare IT buying behaviors of hospitals based on the hospital’s tax status and an annual report of the U.S. hospital IT market.

To access the free hospital data and reports, organizations must submit an access application here.

 

 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.